Interview originally published on 06/04/2017 at Pharma's Almanac
Risk Minimization with an Integrated Global Network
Accelerating Time to Market with Integrated Preparative Chromatography Support
Reducing Time to Market with Targeted Regulatory Affairs Support
Corporate Social Responsibility as a Driver for Improved Sustainability
Shire Announces Sale of Oncology Business to Servier for $2.4 Billion
by Gwenaël Servant
International relationships are evolving rapidly. In this time of constant change and uncertainty, pharmaceutical outsourcing, while still offering many benefits, may also carry added risk — unless the outsourcing partner operates a highly integrated global network, has manufacturing locations in key growth markets and brings decades of experience to the table.
by Christophe Berini
With reduced purification times, higher target molecule purities and the ability to quickly separate and identify impurities, preparative chromatography can provide a greater understanding of products and processes while reducing time to the clinic and the market.
by Servier
Paris, France, October 1, 2018 – Servier, an independent international pharmaceutical company, today announced the launch of InnoPreP™ – a new preparative chromatography service offered under its contract development and manufacturing business.
